Jeremy Allgrove (UK)
Dr. Jeremy Allgrove is a consultant paediatric endocrinologist specialising in paediatric diabetes at Barts and The London NHS Trust. He is the representative of The Royal College of Paediatrics and Child Health (RCPCH) on the Diabetes Dataset Advisory Group (for England). Allgrove studied medicine at Corpus Christi College, Cambridge, qualifying in 1973. In 1978 Allgrove and colleagues discovered Triple A syndrome which is named Allgrove Syndrome after him.
Nouchine Hadjikhani (USA)
Nouchine Hadjikhani, MD, PhD, does brain research at Harvard Medical School/MGH, Martinos Center for Biomedical Imaging in Boston, USA where she directs the Neurolimbic Research Laboratory. She is also invited Professor at the Gillberg Neuropsychiatric Center in Gothenburg, Sweden. Her initial focus of research was the visual system, which over time developed into several topics, including migraine, emotion processing and autism. She has a special interest in understanding neurodevelopmental disorders, and how different conditions can affect the processing of emotions expressed not only by facial expression, but also by gaze and by body language. For her research, she has been using different techniques including fMRI, MEG and eye-tracking. She has authored more than 90 peer-reviewed paper, some of them highly cited, and is the author of a book as well as several book chapters. Recently, she was the author of a paper showing that contrary to what had been thought, individuals with autism do not lack affective empathy and that their seemingly uncaring behaviour stems from personal distress and lack of ability to reappraise when observing pain in others, rather than from an absence of concern. Nouchine Hadjikhani received in 2016 the LifeWatch award for her research on autism
Frederick S. Kaplan (USA)
Frederick S. Kaplan, M.D. is The Isaac & Rose Nassau Professor of Orthopaedic Molecular Medicine and Chief of the Division of Molecular Orthopaedic Medicine at the University of Pennsylvania School of Medicine. He is an alumnus of The Johns Hopkins University School of Medicine
In 1989, Kaplan, an orthopaedic surgeon, met a child with fibrodysplasia ossificans progressiva (FOP), a rare and disabling disorder in which the body forms a second skeleton of heterotopic bone. Motivated to know and do more, Kaplan began a pioneering second career in FOP research, work that led to the discovery of the FOP gene, the seminal target for all therapeutic efforts for this condition.
Kaplan directs the only center in the world devoted entirely to this work, has organized the medical and scientific communities worldwide on this rare condition, and is recognized as the world’s leading expert on FOP. In 1997, Kaplan was awarded the first endowed chair in the nation for orthopaedic molecular medicine. In 2009, he was elected to The National Academy of Medicine.
The late Victor McKusick, the father of clinical genetics, described Kaplan as “one of the really outstanding orthopaedic researchers of his generation. His work with FOP has been extraordinary and extends all the way from the patients to the bench and back again. The devotion of the families and the patients to him is testimony to the kind of human being he is.” Cited in 2006, as one of the15 people who make America great, Newsweek noted “the disease was so rare, nobody wanted to deal with it until he came along.”
Wieland Kiess (Germany)
Professor Wieland Kiess is a pediatrician specializing in endocrinology and diabetology. Wieland Kiess studied medicine at the University of Tübingen and the Technical University of Munich (Klinikum Rechts der Isar).
Professor Wieland Kiess was a research fellow at the National Institutes of Health, USA. In 1998, Wieland Kiess was appointed professor of general pediatrics at the University of Leipzig. Professor Wieland Kiess was the Dean of the Medical Faculty of the University of Leipzig (2002-2005), medical and scientific director of the Frauen- und Kindermedizin des Universitätsklinikums Leipzig (2010-2013), president of the German Diabetes Association, president of the German Society of Paediatrics, Children and Aldolescent’s Medicine and the president of German Diabetes Society and German Society of Obesity. For many years he was a member of the Senate of the University of Leipzig. He is a member of many German, European and American professional and scietific societies as well as the editor of many scientific journals. In 2011-2012, he was the president of the European Society for Pediatric Endocrinology and chairman of the Organizing Committee of the 51st Congress of the European Society for Pediatric Endocrinology (ESPE) in 2012. In 2016, prof. Kiess was awarded Andrea-Prader-Preis the highest prize awarded by ESPE.
Bryan King (USA)
Bryan H. King, MD, MBA, is the Robert Porter Distinguished Professor of Psychiatry and Vice Chair of Child and Adolescent Psychiatry for UCSF Health, as well as Vice President for Child Behavioral Health Services at UCSF Benioff Children’s Hospitals.
King served on the American Psychiatric Association’s Neurodevelopmental Disorders Workgroup responsible for writing the new definition of Autism Spectrum Disorder in DSM-5.
A graduate of the Medical College of Wisconsin and the George Washington University School of Business, King has previously held faculty appointments at the UCLA David Geffen School of Medicine and Dartmouth Medical School. He has worked in a number of key clinical leadership positions at Seattle Children’s Hospital, the Dartmouth-Hitchcock Medical Center and Children’s Hospital at Dartmouth-Hitchcock, and the UCLA Neuropsychiatric Institute and Hospital.
King is a Fellow of the American Psychiatric Association (APA) and a member of the American College of Psychiatrists (ACP), and a Distinguished Fellow of the American Academy of Child and Adolescent Psychiatry (AACAP). He has been the recipient of numerous awards and honors throughout his career, including AACAP’s George Trajan Award for Contributions in Developmental Disabilities (1995) and APA’s Frank J. Menolascino Award for Psychiatric Services for Persons with Intellectual Development Disorders/Developmental Disabilities (2001).
King’s research has focused largely on clinical trials in Autism and Intellectual Disability. He has authored more than 120 academic publications and has participated in several of the major multi-site medication trials in autism spectrum disorder. He will be collaborating with the outstanding faculty and students in Rzeszów to support research, education and clinical service delivery.
Berthold V. Koletzko (Germany)
Berthold V. Koletzko is professor of Pediatrics and head of the Division of Metabolic and Nutritional Medicine at Hauner Children’s Hospital, University of Munich Medical Center, in Munich, Germany. Following work at pediatric departments in South Africa and Tanzania, he qualified in pediatrics at the Children’s Hospital, University of Düsseldorf, Germany. He worked as a post-doc in clinical nutrition and metabolism at the Hospital for Sick Children, University of Toronto, Canada.
Koletzko’s research focuses on metabolism and nutrition in childhood, pregnancy and lactation, metabolic diseases and clinical nutrition. He has co-authored more than 750 publications and received numerous awards and honors. He serves as coordinator of Collaborative Research Programmes, including the Early Nutrition Programming of Adult Health project (www.early-nutrition.org), the Multidisciplinary Early Modification of Obesity Risk Project and the EU Research Network on Malnutrition and Outcome in Hospitalized Children.
Scientific leadership roles include editor, Annals of Nutrition and Metabolism; associate editor, Current Opinion Clinical Nutrition and Metabolic Care; chair, Committee on Nutrition of the German Society of Pediatrics; chair, Child Health Foundation; scientific advisor, Forum Early Childhood Advancement of the German Federal Family Minister, Managing Council, National Platform on Nutrition and Physical Activity; chair, Scientific Board of the Federal Government Network for Young Families; scientific advisor, Committee on Environment, Health and Consumer Protection of the European Parliament; past-president, German Society for Nutritional Medicine; and past-chair, ESPGHAN Committee on Nutrition.
Paul V. Lehmann (USA)
Prof. Paul V. Lehmann, M.D., Ph.D. serves as Chief Executive Officer and President of Cellular Technology Limited and Founded in 2008. Dr. Lehmann has 24 years of ELISPOT Experience. In 1993, Dr. Lehmann joined the faculty at Case Western Reserve University (CWRU), Department of Pathology, where he became a Full Professor and was awarded tenure in 2002. From 2002 to 2006, he was a Permanent Member of the NIH Study Section Immunological Sciences (HAI). He was a postdoctoral fellow with Dr. Eli Secarz at UCLA. He is a graduate of the School of Medicine, University of Tubingen, Germany, where he acquired an M.D. in 1983 and a Ph.D. in 1988.
Prof. Lehmann authored over 170 peer reviewed papers (published in Nature, Science, PNAS, Nature Medicine), which reach number of 10 996 citations (Hirsch index =43).
Prof. Lehmann have been studying the T cell system’s response to “self” and “foreign” antigens as it pertains to autoimmune diseases, infections, and transplantation. By performing such experiments, we learned that T cell recognition of self antigens gradually diversifies in experimentally-induced autoimmune disease (experimental allergic encephalomyelitis in mice, a disease model for multiple sclerosis) and also in naturally occurring autoimmune disease (insulin-dependent diabetes mellitus in mice, a model for human juvenile diabetes).
Grzegorz Telega (USA)
Dr Grzegorz Telega is a pediatric gastroenterologist in Milwaukee, Wisconsin and is affiliated with multiple hospitals in the area, including Children’s Hospital of Wisconsin and Froedtert Hospital and the Medical College of Wisconsin. He received his medical degree from Jagiellonian University Medical College and has been in practice for more than 20 years. He is Medical Director of Pediatric Liver Disease Program, Children’s Hospital of Wisconsin/Medical College of Wisconsin, Division of Pediatric Gastroenterology and Nutrition, Milwaukee, USA; Medical Director of Celiac Disease Program, Children’s Hospital of Wisconsin/Medical College of Wisconsin, Division of Pediatric Gastroenterology and Nutrition, Milwaukee, USA; Associate Chief, Children’s Hospital of Wisconsin/Medical College of Wisconsin, Divisionof Pediatric Gastroenterology and Nutrition, Milwaukee, USA. Dr Telega was mentor of MCW students, faculty, residents and clinical/research fellows. He authored multiple medical and research articles.
Janet Treasure (UK)
Professor Janet Treasure OBE, PhD, FRCP, FRCPsych, has specialised in the treatment of eating disorders at the South London and Maudsley Hospital and also has had an academic career Kings College London for the majority of her career. She was made a Professor of Psychiatry in 2000. The unit is one of the premier European academic centres for eating disorders. The team have co-produced interventions with recovered patients and carers using some of the newest technologies including iPod, DVDs and web based interventions. In 2013 she was given an OBE for her work in eating disorders. Her research has led to greater understanding of, and better treatments for, anorexia, bulimia and binge eating disorders. As well as editing professional texts, Janet has written several self help books for people with eating disorders. Guided self-help using books such as these are recommended in the NICE guidelines as a first stage of treatment.
I have been involved in a large range of research activities centred on eating disorder. These range from genetic, biological and neuroscience research through to pharmacological and psychosocial interventions. We have co-produced interventions with recovered patients and carers using some of the newest technologies including iPod, DVDs and web based platforms.
Arunas Valiulis (Lithuania)
Professor Arunas Valiulis, MD PhD, is full Professor of Paediatrics of Clinic of Children’s Diseases (since 2002) and Institute of Public Health (since 2012), CEO of Private Clinic of Asthma, Allergy and Chronic Lung Diseases (since 2008), President of Lithuanian Paediatric Society (since 2007) and Lithuanian Paediatric Respiratory Society (since 1996), Executive Commity Member of European Academy of Paediatrics EAP-UEMS (sine 2012), founder and Editor-in-Chief of journals “Paediatric Pulmonology and Allergology” (first Index Copernicus ranking scientific journal in Baltic States) and “Lithuanian Paediatric Chronicle”, Chairman of Lithuanian Committee of Evidence Based Guidelines in Paediatric Pulmonology, National Representative in ARIA and GINA Guidelines, Advisor of Minister of Health of Lithuania. He graduated Vilnius University Faculty of Medicine in 1986 and have received postgraduate training in general paediatrics and paediatric pulmonology in London Royal Brompton Hospital, UK, Oxford John Radcliffe Hospital, UK, Ottawa University Children’s Hospital, Canada, Zalcburg University, Austria, Scientific Academy of Lower Austria, Krems, Austria (basic sciences), Gotheborg University, Gotheborg, Sweden (human ecology). He comleted PhD thesis in Russian Academy of Medical Sciences in Moscow in 1992 (respiratory distress syndrome in preterm infants). As visiting professor he conducted short-term training courses in Virginia University Children’s Hospital in Richmond, USA, Wake Forest Pulmonologic Center in Winston Salem, USA, Chapel Hill Pulmonologic Center of University of North Carolina, USA, Tampere University Children’s Hospital, Finland, Tbilisi State University, Georgia, State University of Medicine and Pharmacy “Nicolae Testemitanu” of Moldova, Kishinev, Republic of Moldova, Miami University Miller School of Medicine & Holtz Children’s Hospital, USA.
He was Founder in 1996 and Chairman of Vilnius International Paediatric Pulmonology Conference – School (18 Annual Vilnius International Conference – Schools of Paediatric Asthma, Pneumonia, Cystic Fibrosis, Tuberculosis and Orphan Lung Diseases; totally more than 5000 trained doctors), Founder and Chairman of Biannual Lithuanian National Asthma Congresses, Founder of Lithuanian Council of Asthma Clubs (national organization of patients with chronic respiratory diseases), Chairman of 3 Lithuanian Congresses on Paediatric Pulmonology and 2 International Conferences on Human Ecology, Chairman of Organizing Committee of Annual Congress of European Academy of Childhood Disability (Vilnius, June 2009), President of 1st Baltic Paediatric Congress together with Annual Conference of European Academy of Paediatrics and European Confederation of Primary Care Paediatricians (Vilnius, May 2011). Invited abroad lectureship during last 5 years: pneumonia (Bishkek 2009, Tbilisi 2010, Yerevan 2010, Moscow 2011, 2012, Richmond 2012, Kishinev 2013), asthma (Berlin 2008, Vienna 2009, Tbilisi 2012, Miami 2013), allergy (Nice 2008), TB (Tbilisi 2008, Vienna 2010, Miami 2013), CF (North Carolina 2006), chronic cough (Vienna 2010, Copenhagen 2010, Barselona, 2011), organization of health service (North Carolina 2006, Oslo 2008, Bishkek 2009, Tallinn 2012, Richmond 2012, Kishinev 2013, Miami 2013). He is National Coordinator of EU Leonardo da Vinci Project „Introducing standards of the best medical practice for the patients with inherited Alpha-1 Antitrypsin Deficiency in Central Eastern Europe“ (2011-2013) and author of more than 120 scientific papers, chapters of books, textbooks including European MasterCourse in Paediatrics: A Complete Course for the European Paediatric Common Trunk. He is Chief of Executive Committee of IPOKRaTES Lithuania Foundation since 1994, Vice-Chairman of Mother and Child Health Commission and Member of Allergologic Commission of Lithuanian Academy of Sciences since 2001, National Coordinator of Global Alliance Against Chronic Respiratory Diseases (WHO GARD Lithuania) since 2007, National Coordinator in Strategis Pediatric Alliance for the Future Health of Children in Europe since 2011, Honorary Fellow of British Royal College of Paediatrics and Child Health.